▼ 0.08%
prev close
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Congressional Trades
21
All tracked trades
Members Trading
18
Unique members
Net Activity
+3
12 buys · 9 sells
Members Who Traded This Stock
21 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2026-01-16 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 121d ago | — | |
| 2025-12-03 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 180d ago | — | |
| 2025-10-24 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 218d ago | — | |
| 2025-09-25 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 224d ago | — | |
| 2025-09-04 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 243d ago | — | |
| 2025-04-15 | AMGNAmgen Inc | Sell | $15,001 - $50,000 | 384d ago | — | |
| 2025-04-08 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 391d ago | — | |
| 2025-02-24 | AMGNAmgen Inc | Buy | $15,001 - $50,000 | 451d ago | — | |
| 2025-02-11 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 287d ago | — | |
| 2024-12-06 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 513d ago | — | |
| 2024-10-23 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 141d ago | — | |
| 2024-08-07 | AMGNAmgen Inc | Buy | $50,001 - $100,000 | 652d ago | — | |
| 2024-08-07 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 335d ago | — | |
| 2024-01-02 | AMGNAmgen Inc | Sell | $15,001 - $50,000 | 863d ago | — | |
| 2023-10-24 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 937d ago | — | |
| 2023-03-06 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 1140d ago | — | |
| 2022-10-19 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 1301d ago | — | |
| 2022-09-26 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 1337d ago | — | |
| 2022-05-11 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 1448d ago | — | |
| 2021-03-04 | AMGNAmgen Inc | Buy | $15,001 - $50,000 | 1370d ago | — | |
| 2019-09-27 | AMGNAmgen Inc | Buy | $15,001 - $50,000 | 1028d ago | — |
2026-01-16
David J. Taylor
AMGN
Amount
$1,001 - $15,000
Filed
121d ago
2025-12-03
David J. Taylor
AMGN
Amount
$1,001 - $15,000
Filed
180d ago
2025-10-24
Marjorie Taylor Greene
AMGN
Amount
$1,001 - $15,000
Filed
218d ago
2025-09-25
Lisa McClain
AMGN
Amount
$1,001 - $15,000
Filed
224d ago
2025-09-04
Sheldon Whitehouse
AMGN
Amount
$1,001 - $15,000
Filed
243d ago
2025-04-15
Tommy Tuberville
AMGN
Amount
$15,001 - $50,000
Filed
384d ago
2025-04-08
Rob Bresnahan
AMGN
Amount
$1,001 - $15,000
Filed
391d ago
2025-02-24
Jefferson Shreve
AMGN
Amount
$15,001 - $50,000
Filed
451d ago
2025-02-11
Daniel Meuser
AMGN
Amount
$1,001 - $15,000
Filed
287d ago
2024-12-06
Virginia Foxx
AMGN
Amount
$1,001 - $15,000
Filed
513d ago
2024-10-23
Julia Letlow
AMGN
Amount
$1,001 - $15,000
Filed
141d ago
2024-08-07
C. Scott Franklin
AMGN
Amount
$50,001 - $100,000
Filed
652d ago
2024-08-07
Scott Scott Franklin
AMGN
Amount
$1,001 - $15,000
Filed
335d ago
2024-01-02
Michael C. Burgess
AMGN
Amount
$15,001 - $50,000
Filed
863d ago
2023-10-24
Greg Stanton
AMGN
Amount
$1,001 - $15,000
Filed
937d ago
2023-03-06
Josh Gottheimer
AMGN
Amount
$1,001 - $15,000
Filed
1140d ago
2022-10-19
Josh Gottheimer
AMGN
Amount
$1,001 - $15,000
Filed
1301d ago
2022-09-26
Earl Blumenauer
AMGN
Amount
$1,001 - $15,000
Filed
1337d ago
2022-05-11
Josh Gottheimer
AMGN
Amount
$1,001 - $15,000
Filed
1448d ago
2021-03-04
Carol Devine Miller
AMGN
Amount
$15,001 - $50,000
Filed
1370d ago
2019-09-27
Richard W. Allen
AMGN
Amount
$15,001 - $50,000
Filed
1028d ago
Recent News
Powered by Polygon.io
President Trump Loaded Up on Eli Lilly in Q1. Should You Buy the Obesity Drug Stock Too?
AI Bots Crashed $10K in 2 Weeks While This ’Beat-the-Bot’ Divvie Sails Higher
My Personal Plan to Turn Market Chaos Into 300%+ Growth
CytomX Therapeutics to Present at Upcoming June Investor Conferences
Eli Lilly Stock: Next Stop $2,000?
Trade Timeline
Congressional activity, newest first
David J. Taylor
2026-01-16 · Purchase
$1,001 - $15,000
David J. Taylor
2025-12-03 · Sale
$1,001 - $15,000
Marjorie Taylor Greene
2025-10-24 · Purchase
$1,001 - $15,000
Lisa McClain
2025-09-25 · Sale
$1,001 - $15,000
Sheldon Whitehouse
2025-09-04 · Sale
$1,001 - $15,000
Tommy Tuberville
2025-04-15 · Sale
$15,001 - $50,000
Rob Bresnahan
2025-04-08 · Sale
$1,001 - $15,000
Jefferson Shreve
2025-02-24 · Purchase
$15,001 - $50,000
Daniel Meuser
2025-02-11 · Sale
$1,001 - $15,000
Virginia Foxx
2024-12-06 · Purchase
$1,001 - $15,000
Julia Letlow
2024-10-23 · Purchase
$1,001 - $15,000
C. Scott Franklin
2024-08-07 · Purchase
$50,001 - $100,000
Scott Scott Franklin
2024-08-07 · Purchase
$1,001 - $15,000
Michael C. Burgess
2024-01-02 · Sale
$15,001 - $50,000
Greg Stanton
2023-10-24 · Sale
$1,001 - $15,000
Josh Gottheimer
2023-03-06 · Sale
$1,001 - $15,000
Josh Gottheimer
2022-10-19 · Purchase
$1,001 - $15,000
Earl Blumenauer
2022-09-26 · Purchase
$1,001 - $15,000
Josh Gottheimer
2022-05-11 · Purchase
$1,001 - $15,000
Carol Devine Miller
2021-03-04 · Purchase
$15,001 - $50,000
Richard W. Allen
2019-09-27 · Purchase
$15,001 - $50,000